@DiabetesMine @t1international @abschaffer @KOIinsulin4all UHC/OptumRx removed all long-lasting except for Basaglar. I had tried Basaglar before, but I had so many severe lows on it while managing my life on the midnight shift that it was decided to figure out discount cards & other ways to get Lantus/Toujeo. That’s how I got thru ‘17
All these lantus half dabarhdoos by the nation twitter.com/saadiraja183/s…
@RESachs Why assuming that pharma is the only driver in insulin prices? It seem unreasonable to assume that PBM are uninvolved Remember Merck had an approved Lantus insulin biosimilar but dropped it due to "market structure and cost of production costs" Market structure = PBM contracts?
lots of options with lots of big price tags: syringes, lancets, pens, glucose tabs, test strips, meters, glucagon emergency kits, keytone strips, insulin resistance drugs, humalog, novalog, lantus, cartridges, insets, pumps, continuous glucose monitors, transmitters, sensors...
@SanofiUS I guess I’m not in enough need to get Lantus at a sane price. When I first got a prescription, many years ago, it was US$55 a vial. Now it’s over four times that. You pretend you care about people who use it, and sell a little at reasonable prices to the poor. Better than nothing
@JimmyDaugherty I didn't find out about the Walmart insulin until I had pretty much gone broke spending $600/mo on Lantus & Humalog without insurance! Docs don't tell you -- I had to learn about it from another broke diabetic! AND I WAS SO MAD. Haha. I also lived in Bellingham, no idea about CA!
A new Kaiser report finds that retirees’ spending on specialty drugs – defined as costing more than $670 per month – can range from $2,700 to $16,500 per year. Specialty drugs include Lantus, Zepatier for hepatitis C, Humira for rheumatoid arthritis &cancer drugs like Idhifa. twitter.com/Burke_Esq/stat…
@mariskreizman One thing many liberals fail to appreciate is that regulation is a large part of what makes life-sustaining medicine unaffordable. Lantus is off-patent but it's uneconomic to get a biosimilar approved and market it. The regulation sustains these monopolies/oligopolies.
@ellenthoen @bloodsukker1 @KEI_DC @MSF_access @SharonannMSF @t1international @jamie_love @ThiruGeneva @novonordisk @Diabetes_Sanofi @LillyDiabetes @Jandelliott Yes, I get targeted by right-wing lunatics and @twitter does nothing. Now they go after someone posting about global health. Write to Matthew Derella <email@example.com>.